Several variants in SLC39A8 have been associated with rare monogenic diseases, such as CDG type IIn and Leigh syndrome (4–6), as well as more common polygenic diseases including IBD, cardiometabolic disease, schizophrenia, and Parkinson’s disease, among others (32–34). Here, SLC39A8 is linked to Leigh syndrome.